{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:01Z","timestamp":1791910621391,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["apjon.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Oncology Nursing"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.apjon.2026.100983","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:59:26Z","timestamp":1779206366000},"page":"100983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quality of patient-reported outcome reporting and related trial characteristics in randomized controlled trials of cancer pain: A systematic review based on the CONSORT-PRO extension"],"prefix":"10.1016","volume":"13","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiying","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-2567","authenticated-orcid":false,"given":"Jinxia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"7","key":"10.1016\/j.apjon.2026.100983_bib2","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.3390\/curroncol30070500","article-title":"Cancer pain management: a narrative review of current concepts, strategies, and techniques","volume":"30","author":"Mestdagh","year":"2023","journal-title":"Curr Oncol"},{"issue":"8","key":"10.1016\/j.apjon.2026.100983_bib3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.6004\/jnccn.2013.0119","article-title":"Adult cancer pain","volume":"11","author":"Swarm","year":"2013","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/papr.12711","article-title":"PROMs for pain in adult cancer patients: a systematic review of measurement properties","volume":"19","author":"Abahussin","year":"2019","journal-title":"Pain Pract"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.rdc.2019.01.006","article-title":"Patient-reported outcomes measurement information system versus legacy instruments: are they ready for prime time?","volume":"45","author":"Bykerk","year":"2019","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.apjon.2026.100983_bib6","series-title":"ISOQOL Dictionary of Quality of Life and Health Outcomes Measurement","author":"Mayo","year":"2015"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PPO.0000000000000401","article-title":"Patient-reported outcomes in integrative oncology bridging clinical care with research","volume":"25","author":"Lopez","year":"2019","journal-title":"Cancer J"},{"key":"10.1016\/j.apjon.2026.100983_bib8","first-page":"61","article-title":"Article commentary: patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.apjon.2026.100983_bib9","unstructured":"European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient-reported outcome (PRO) measures in oncology studies. https:\/\/www.ema.europa.eu\/en\/appendix-2-guideline-evaluation-anticancer-medicinal-products-man-use-patient-reported-outcome-pro-measures-oncology-studies-scientific-guideline Accessed 7 November 2025."},{"issue":"24","key":"10.1016\/j.apjon.2026.100983_bib10","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1200\/JCO.2016.68.2518","article-title":"Updating the American society of clinical oncology value framework: revisions and reflections in response to comments received","volume":"34","author":"Schnipper","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.apjon.2026.100983_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European society for medical oncology magnitude of clinical benefit scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41687-023-00565-z","article-title":"Routine patient assessment and the use of patient-reported outcomes in specialized palliative care in Japan","volume":"7","author":"Ito","year":"2023","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib13","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/S1470-2045(22)00654-4","article-title":"Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group","volume":"24","author":"Piccinin","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.apjon.2026.100983_bib14","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.injury.2019.10.073","article-title":"Patient-reported outcomes: which ones are most relevant?","volume":"51","author":"Van Lieshout","year":"2020","journal-title":"Injury"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11644","article-title":"Application of patient-reported outcome measurements in clinical trials in China","volume":"5","author":"Zhou","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"suppl 1","key":"10.1016\/j.apjon.2026.100983_bib16","doi-asserted-by":"crossref","first-page":"i66","DOI":"10.1093\/annonc\/mdw080","article-title":"Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned","volume":"27","author":"Friedlander","year":"2016","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols the SPIRIT-PRO extension","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12955-019-1181-2","article-title":"Impact of missing data on bias and precision when estimating change in patient-reported outcomes from a clinical registry","volume":"17","author":"Ayilara","year":"2019","journal-title":"Health Qual Life Outcome"},{"issue":"3","key":"10.1016\/j.apjon.2026.100983_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11136-018-2016-z","article-title":"A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)","volume":"28","author":"Ishaque","year":"2019","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.apjon.2026.100983_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.apjon.2026.100983_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11136-017-1508-6","article-title":"Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension","volume":"26","author":"Mercieca-Bebber","year":"2017","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.apjon.2026.100983_bib22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/JU.0000000000001841","article-title":"Apalutamide plus androgen deprivation therapy for metastatic castration-sensitive prostate cancer: analysis of pain and fatigue in the phase 3 TITAN study","volume":"206","author":"Agarwal","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1185\/03007995.2016.1157060","article-title":"Impact of palbociclib plus letrozole on pain severity and pain interference with daily activities in patients with estrogen receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast cancer as first-line treatment","volume":"32","author":"Bell","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.apjon.2026.100983_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.42482","article-title":"Acupuncture vs massage for pain in patients living with advanced cancer: the IMPACT randomized clinical trial","volume":"6","author":"Epstein","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"14","key":"10.1016\/j.apjon.2026.100983_bib25","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/cncr.35282","article-title":"Virtual reality for pain management in hospitalized patients with cancer: a randomized controlled trial","volume":"130","author":"Groninger","year":"2024","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1188\/18.ONF.260-272","article-title":"Improving functional status in African Americans with cancer pain: a randomized clinical trial","volume":"45","author":"Hazard Vallerand","year":"2018","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/09645284211056016","article-title":"Acupuncture combined with opioids for cancer pain: a pilot pragmatic randomized controlled trial","volume":"40","author":"He","year":"2021","journal-title":"Acupunct Med"},{"issue":"9","key":"10.1016\/j.apjon.2026.100983_bib28","first-page":"5227","article-title":"Clinical efficacy and implementation issues of an electronic pain reporting device among outpatients with cancer","volume":"29","author":"Judge","year":"2021","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.apjon.2026.100983_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpainsymman.2024.05.033","article-title":"A digital therapeutic application (ePAL) to manage pain in patients with advanced cancer: a randomized controlled trial","volume":"68","author":"Kamdar","year":"2024","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"10.1016\/j.apjon.2026.100983_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s11764-021-01081-z","article-title":"Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial","volume":"16","author":"Knoerl","year":"2021","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib31","first-page":"16","article-title":"Transcutaneous electrical acupoint stimulation for cancer-related pain management in patients receiving chronic opioid therapy: a randomized clinical trial","volume":"32","author":"Lyu","year":"2023","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jamaoncol.2021.0310","article-title":"Effectiveness of electroacupuncture or auricular acupuncture vs usual care for chronic musculoskeletal pain among cancer survivors the PEACE randomized clinical trial","volume":"7","author":"Mao","year":"2021","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.apjon.2026.100983_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/phar.2875","article-title":"CYP2D6-guided opioid therapy for adults with cancer pain: a randomized implementation clinical trial","volume":"43","author":"Mosley","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","article-title":"Pain response after stereotactic body radiation therapy versus conventional radiation therapy in patients with bone Metastases: A phase 2 randomized controlled trial within a prospective cohort","volume":"110","author":"Pielkenrood","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12885-020-06729-0","article-title":"Implementation of a nurse-led self-management support intervention for patients with cancer-related pain: a cluster randomized phase-IV study with a stepped wedge design (EvANtiPain)","volume":"20","author":"Raphaelis","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.apjon.2026.100983_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","article-title":"Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine phase 3 results of NRG oncology\/RTOG 0631 randomized clinical trial","volume":"9","author":"Ryu","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.apjon.2021.12.003","article-title":"Randomized clinical trial to evaluate a cancer pain self-management intervention for outpatients","volume":"9","author":"Valenta","year":"2022","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"7","key":"10.1016\/j.apjon.2026.100983_bib38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/pon.6151","article-title":"Meaning-centered pain coping skills training for patients with metastatic cancer: results of a randomized controlled pilot trial","volume":"32","author":"Winger","year":"2023","journal-title":"Psychooncology"},{"issue":"5","key":"10.1016\/j.apjon.2026.100983_bib39","doi-asserted-by":"crossref","DOI":"10.2196\/12542","article-title":"Development and testing of a Mobile app for pain management among cancer patients discharged from hospital treatment: randomized controlled trial","volume":"7","author":"Yang","year":"2019","journal-title":"JMIR mHealth uHealth"},{"issue":"8","key":"10.1016\/j.apjon.2026.100983_bib40","doi-asserted-by":"crossref","DOI":"10.2196\/24555","article-title":"Effect of physician-pharmacist participation in the management of ambulatory cancer pain through a digital health platform: randomized controlled trial","volume":"9","author":"Zhang","year":"2021","journal-title":"JMIR mHealth uHealth"},{"issue":"6","key":"10.1016\/j.apjon.2026.100983_bib41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.eururo.2018.11.033","article-title":"Cabozantinib versus mitoxantrone-prednisone in symptomatic metastatic castration-resistant prostate cancer: a randomized phase 3 trial with a primary pain endpoint","volume":"75","author":"Basch","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/nop\/npaa074","article-title":"Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients","volume":"8","author":"Garnier","year":"2021","journal-title":"Neuro-Oncol Pract"},{"issue":"12","key":"10.1016\/j.apjon.2026.100983_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058197","article-title":"Quality and reporting of patient-reported outcomes in elderly patients with hip fracture: a systematic review","volume":"12","author":"van der Vet","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.apjon.2026.100983_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1246938","article-title":"Low-quality of patient-reported outcome reporting in randomized clinical trials of major depressive disorder-a meta-epidemiological review","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Psychiatr"},{"issue":"2","key":"10.1016\/j.apjon.2026.100983_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11126-023-10017-y","article-title":"Assessment of reporting of patient-reported outcomes in randomized controlled trials for interventions of post-traumatic stress disorder","volume":"94","author":"Hughes","year":"2023","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.apjon.2026.100983_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103747","article-title":"Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: a systematic review","volume":"176","author":"Waisberg","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"13","key":"10.1016\/j.apjon.2026.100983_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7450","article-title":"Common patient-reported sources of cancer-related distress in adults with cancer: a systematic review","volume":"13","author":"Stevens","year":"2024","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.apjon.2026.100983_bib48","article-title":"Adult cancer pain, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Swarm","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41687-018-0056-3","article-title":"Literature review to assemble the evidence for response scales used in patient-reported outcome measures","volume":"2","author":"Gries","year":"2018","journal-title":"J Patient Rep Outcomes"},{"issue":"16","key":"10.1016\/j.apjon.2026.100983_bib50","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1002\/cam4.4111","article-title":"International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: a qualitative study","volume":"10","author":"Retzer","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.apjon.2026.100983_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010938","article-title":"Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review","volume":"6","author":"Mercieca-Bebber","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.apjon.2026.100983_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1740774517741113","article-title":"A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data","volume":"15","author":"Palmer","year":"2018","journal-title":"Clin Trials"},{"issue":"10489","key":"10.1016\/j.apjon.2026.100983_bib53","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.apjon.2026.100983_bib54","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2022.6421","article-title":"Ethical considerations for the inclusion of patient-reported outcomes in clinical research: the PRO ethics guidelines","volume":"327","author":"Cruz Rivera","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.apjon.2026.100983_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jss.2024.04.054","article-title":"Factors associated with loss to Follow-Up in surgical trials: a systematic review and meta-analysis","volume":"300","author":"Walker","year":"2024","journal-title":"J Surg Res"},{"issue":"14","key":"10.1016\/j.apjon.2026.100983_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015361","article-title":"Bias and loss to Follow-Up in cardiovascular randomized trials: a systematic review","volume":"9","author":"Fong","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apjon.2026.100983_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103819","article-title":"Incomplete reporting of patient-reported outcomes in multiple sclerosis: a meta-epidemiological study of randomized controlled trials","volume":"63","author":"Khan","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.apjon.2026.100983_bib58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1477-7525-11-184","article-title":"The CONSORT patient-reported outcome (PRO) extension: implications for clinical trials and practice","volume":"11","author":"Calvert","year":"2013","journal-title":"Health Qual Life Outcome"}],"container-title":["Asia-Pacific Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562526001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562526001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:36:45Z","timestamp":1791909405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2347562526001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S2347562526001332"],"URL":"https:\/\/doi.org\/10.1016\/j.apjon.2026.100983","relation":{},"ISSN":["2347-5625"],"issn-type":[{"value":"2347-5625","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of patient-reported outcome reporting and related trial characteristics in randomized controlled trials of cancer pain: A systematic review based on the CONSORT-PRO extension","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjon.2026.100983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Asian Oncology Nursing Society.","name":"copyright","label":"Copyright"}],"article-number":"100983"}}